Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Neelakantam Biradhar"'
Autor:
Sridevi V. Nimmagadda, Shukra M. Aavula, Neelakantam Biradhar, Dev Chandran, Rajendra Lingala, Srinivasan Alwar Villuppanoor, Samuel Sula
Publikováno v:
Biotechnology Research International
Recombinant antibody phage display technology is a vital tool that facilitates identification of specific binding molecules to a target enabling the rapid generation and selection of high affinity, fully human, or mouse antibody product candidates es
Autor:
Nagendrakumar Balasubramanian Singanallur, Shukra M. Aavula, Nagarajan Thirumeni, Dev Chandran, Neelakantam Biradhar, Rajalakshmi Shanmugham, Sridevi V. Nimmagadda, Srinivasan Alwar Villuppanoor, Varaprasada Sankarasetty Rao
Publikováno v:
Clinical and Vaccine Immunology. 17:1261-1268
The potency of rabies vaccines, determined using the NIH mouse protection test, can be directly correlated to the amount of rabies virus glycoprotein (RV GP) present in the vaccine. In an effort to develop a simple and sensitive enzyme-linked immunos
Autor:
Samuel Sula, Shukra M. Aavula, Sridevi V. Nimmagadda, Neelakantam Biradhar, Dev Chandran, Srinivasan Alwar Villuppanoor, Rajendra Lingala
Publikováno v:
Biologicals : journal of the International Association of Biological Standardization. 40(4)
Phage display technology has been utilized for identification of specific binding molecules to an antigenic target thereby enabling the rapid generation and selection of high affinity, fully human antibodies directed towards disease target appropriat